The development of anticancer ruthenium( ii ) complexes: from single molecule compounds to nanomaterials
Top Cited Papers
- 27 June 2017
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 46 (19) , 5771-5804
Abstract
This review covers ruthenium( ii ) complexes as anticancer drugs in single molecules and nanomaterials and includes targets, mechanisms, SAR, PDT and nano-systems.Keywords
This publication has 329 references indexed in Scilit:
- Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cellsJournal of Inorganic Biochemistry, 2012
- The Art of Filling Protein Pockets Efficiently with Octahedral Metal ComplexesAngewandte Chemie International Edition, 2012
- Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase InhibitorsJournal of the American Chemical Society, 2011
- Targeting a ruthenium complex to the nucleus with short peptidesBioorganic & Medicinal Chemistry, 2010
- From Imide to Lactam Metallo-pyridocarbazoles: Distinct Scaffolds for the Design of Selective Protein Kinase InhibitorsThe Journal of Organic Chemistry, 2009
- Fluorescein Redirects a Ruthenium−Octaarginine Conjugate to the NucleusJournal of the American Chemical Society, 2009
- Transferring the Concept of Multinuclearity to Ruthenium Complexes for Improvement of Anticancer ActivityJournal of Medicinal Chemistry, 2009
- Mechanism of Cellular Uptake of a Ruthenium Polypyridyl ComplexBiochemistry, 2008
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing DeviceJournal of the American Chemical Society, 2008
- Methods to Explore Cellular Uptake of Ruthenium ComplexesJournal of the American Chemical Society, 2006